ArticleNeuro-oncology2014

MYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous system .

Marco Gessi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.